KLAC vs RCUS · P/E 55, rev $13.58B vs rev $58.0M
KLA Corporation (KLAC) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported KLAC revenue for 2026-06-30 was $13.58B. Net income was $4.83B. Revenue was up 11.7% from 2025-06-30 to 2026-06-30. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Latest reported RCUS revenue for 2026-06-30 was $58.0M. Net income was -$219.0M. RCUS currently screens at market cap $885.2M.
KLAC currently screens at market cap $252.01B and trailing P/E 54.7. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the KLAC and RCUS stock pages for the full models.
Not investment advice.